SCHEMBL14083840

SCHEMBL14083840

CCOc1ccc(NC(=O)c2ccc(-c3ncccc3Cl)c(OC)c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 0.56
▸ RAB9A P51151 6/20 0.56
▸ KDM4E B2RXH2 3/20 0.55
▸ ALDH1A1 P00352 2/20 0.55
▸ CYP1A2 P05177 1/20 0.55
▸ SMN1; SMN2 Q16637 5/20 0.54
▸ MAPT P10636 3/20 0.54
▸ GAA P10253 2/20 0.54
▸ PPARG P37231 1/20 0.53
▸ RXFP1 Q9HBX9 1/20 0.53
▸ NCOR2 Q9Y618 1/20 0.53
▸ MITF O75030 1/20 0.53
▸ PKM P14618 1/20 0.53
▸ AURKB Q96GD4 1/20 0.52
▸ KMT2A Q03164 3/20 0.51
▸ TP53 P04637 2/20 0.51
▸ LMNA P02545 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ AHR P35869 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083833 0.92 MAPT (0.54) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL14083730 0.92 AURKB (0.55) NPC1RAB9AKDM4EALDH1A1SMN1; SMN2
SCHEMBL14083838 0.90 SMN1; SMN2 (0.52) NPC1RAB9AALDH1A1CYP1A2SMN1; SMN2
SCHEMBL14083809 0.89 MAPT (0.58) NPC1RAB9AKDM4EALDH1A1CYP1A2
SCHEMBL14083835 0.89 AURKB (0.56) NPC1RAB9AALDH1A1CYP1A2SMN1; SMN2
SCHEMBL14083820 0.89 MEN1 (0.58) NPC1RAB9AKDM4EALDH1A1CYP1A2
SCHEMBL14083719 0.88 NPC1 (0.56) NPC1RAB9AKDM4EALDH1A1CYP1A2
SCHEMBL14083841 0.88 AURKB (0.55) KDM4EALDH1A1MAPTPKMAURKB
SCHEMBL14083729 0.87 AURKB (0.57) NPC1RAB9AALDH1A1SMN1; SMN2MAPT
SCHEMBL14083771 0.87 ALDH1A1 (0.54) NPC1RAB9AALDH1A1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 NPC1 1061/4885RAB9A 1914/4885KDM4E 4231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback